Senior Medical Specialist - Denmark
Senior Medical Specialist
Research and Development
22 July 2017
We are looking for an experienced physician with a Medical Degree, and, ideally, with a completed training in Psychiatry (board certification) and experience in the practice of medicine.
The Department of Clinical Development – Psychiatry has global responsibility for the scientific aspects of bringing new compounds to the market for the treatment of Mood Disorders (depression) and Psychosis (schizophrenia). The members of the department are experienced physicians and scientists who are located in Denmark, France and the US. We contribute to clinical development plans, study protocols, regulatory submissions and the Lundbeck Disease Strategy Groups. Our members present at investigator meetings, congresses and in meetings with regulators. Internally, we work in project teams and have close collaborations with Preclinical Research, Clinical Operations (Clinical Study Management), Regulatory Affairs, Drug Safety and Medical Affairs.
The Position will be located at the Lundbeck company headquarter in Copenhagen (Valby,) Denmark
Your job and key responsibilities(sentences with max 2 -3 bullets)
You will be involved in the design and conduct of clinical trials in depression and / or schizophrenia as a Medical Expert or Medical Monitor providing scientific and medical advice to the study team. You will also be involved in internal trainings and scientific presentations. The role requires the ability to travel regularly in Europe and occasionally also overseas (North America, Asia). You will be reporting to the Chief Specialist Mood & Anxiety Disorders who is working out of Copenhagen (Valby)
- Board-certified psychiatrist and solid specialist background in CNS drug development with at least 5 years of previous experience in Clinical Development in a pharmaceutical company or a contract research organisation (CRO)
- Past successful work with international cross-functional teams;
- In-depth knowledge of study methodology, study data review and analysis;
- Excellent knowledge of study publication processes and publications within the Psychiatry Therapeutic Area;
- Good knowledge of study execution, benefit risk management and regulatory affairs
- Proven leadership skills;
- Excellent communication and presentation skills;
- Fluent in written and spoken English;
- Ambitious, goal-oriented and result-driven
For further information, please contact Raimund Buller on RABU@lundbeck.com
or +33 6 87 75 21 66. Your application and CV should not be sent via email.
We also recommend that you have a look at our website.
Please click on the link below to apply for the job.
Applications must be received no later than 22nd July 2017.
Lundbeck is a global pharmaceutical company specialized in psychiatric and neurological disorders. For more than 70 years, we have been at the forefront of research within neuroscience. Our key areas of focus are depression, schizophrenia, Parkinson's disease and Alzheimer's disease.
An estimated 700 million people worldwide are living with psychiatric and neurological disorders and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with psychiatric and neurological disorders – we call this Progress in Mind.
Read more at http://www.lundbeck.com/global/about-us/progress-in-mind.
Our approximately 5,300 employees in 55 countries are engaged in the entire value chain throughout research, development, production, marketing and sales. Our pipeline consists of several late-stage development programmes and our products are available in more than 100 countries. We have research centres in China and Denmark and production facilities in China, Denmark, France and Italy. Lundbeck generated revenue of DKK 14.6 billion in 2015 (EUR 2 billion; USD 2.2 billion).
For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck .